Roche Pharma India introduces a new injectable immunotherapy for lung cancer. This treatment takes only seven minutes, a significant reduct...

Roche Pharma has introduced Tecentriq, India's first under-the-skin immunotherapy for lung cancer. This new injection takes about seven min...

A groundbreaking study published in Nature Medicine reveals that the experimental drug Elraglusib, when combined with standard chemotherapy...

Who was Carrie Everett, and what is her cause of death, family and net worth details? Carrie Everett, former Miss North Carolina 2024, died...

Cancer treatment single injection results: A redesigned immunotherapy, injected directly into tumors, has shown remarkable results in an ea...

AstraZeneca Pharma has secured approval from India's drug regulator for its cancer treatment Trastuzumab Deruxtecan. This drug is now appro...

Joe Biden’s cancer diagnosis has raised big questions about his health and future. At 82, the former president is battling metastatic prost...

Joe Biden prostate cancer diagnosis has shocked the nation as the 82-year-old former U.S. President is confirmed to have an aggressive form...

Former U.S. President Joe Biden has been diagnosed with an aggressive form of prostate cancer that has spread to his bones, according to a ...

Cipla has secured USFDA approval to market a generic version of Abraxane, paclitaxel protein-bound particles for injectable suspension (100...

In July 2009, the US Food and Drug Administration (USFDA) approved Eli Lilly and Merck's cetuximab (Erbitux) for treatment of metastatic co...

Cetuximab has received approval from the Drug Controller General of India (DCGI) for its effectiveness in treating head and neck cancer

The company has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) fo...

Biocon and Mylan’s proposed biosimilar bevacizumab, a cancer drug, is expected to be the third biosimilar from the partnered portfolio for ...

Treatments, including radiation & immunotherapy, have proven to be effective in patients with metastatic solid cancers.

The partnership will develop and market a generic version of Celgene's ABRAXANE which is used in treatments of breast and lung cancers.

Roche Products (India) Private Ltd is a wholly owned subsidiary of the Switzerland based Roche Group and has products in therapeutic areas .